Polymer Capital Management »

SPDR S&P Biotech shares owned by Polymer Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Polymer Capital Management from 13F filings

Historical chart of Polymer Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Polymer Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Polymer Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.9M 48k 121.93

More positions owned by Polymer Capital Management

Vaneck Etf Trust Semiconductr Etf (SMH)
Eli Lilly & Co. (LLY)
NVIDIA Corporation (NVDA)
Pdd Holdings Sponsored Ads (PDD)
Spdr Gold Tr Gold Shs (GLD)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl C (GOOG)
Summit Therapeutics (SMMT)
Global X Fds Artificial Etf (AIQ)
Broadcom (AVGO)
Vipshop Hldgs Sponsored Ads A (VIPS)
Sandisk Corp (SNDK)
Alnylam Pharmaceuticals (ALNY)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf (KBWB)
Coherent Corp (COHR)

View all positions for Polymer Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
Susquehanna International
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Deep Track Capital
Jane Street
Citadel Advisors
UBS Group
Millennium Management
Point72 Asset Management
Peak6
Wells Fargo & Company
Soleus Capital Management
Barclays

View all funds holding SPDR S&P Biotech